World's Best Scientists 2026 revealed!
Jean-Michel Sallenave

Jean-Michel Sallenave

D-Index & Metrics

Biology and Biochemistry

D-Index
57
Citations
8818
World Ranking
14088
National Ranking
540

Jean-Michel Sallenave publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Jean-Michel Sallenave sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 140 publications — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Jean-Michel Sallenave D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Jean-Michel Sallenave sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 57 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Jean-Michel Sallenave is affiliated with Université Paris Cité in France. Their research primarily focuses on medicine and the intersecting fields of immunology and microbiology, with a specialization in pulmonary and respiratory medicine. The scientist's body of work spans several key subfields including immunology, epidemiology, infectious diseases, and health, toxicology, and mutagenesis.

The research topics addressed by Jean-Michel Sallenave cover a range of areas within respiratory health and immune system interactions. These topics include neonatal respiratory health research, cystic fibrosis research advances, respiratory support and mechanisms, respiratory viral infections research, immune cells in cancer, immune response and inflammation, and immune cell function and interaction.

The scientist has contributed to several publications, notably in the following venues:

  • Frontiers in Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Environmental Pollution
  • Journal of Cystic Fibrosis
  • Biomaterials

Some recent papers reflecting the scope of their work include:

  • Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets? (2020) Frontiers in Immunology
  • Influenza A Virus Pre-Infection Exacerbates Pseudomonas aeruginosa-Mediated Lung Damage Through Increased MMP-9 Expression, Decreased Elafin Production and Tissue Resilience (2020) Frontiers in Immunology
  • Pulmonary delivery of silver nanoparticles prevents influenza infection by recruiting and activating lymphoid cells (2024) Biomaterials
  • To Vaccinate or not: Influenza Virus and Lung Cancer Progression (2021) Trends in cancer
  • IL-6-elafin genetically modified macrophages as a lung immunotherapeutic strategy against Pseudomonas aeruginosa infections (2021) Molecular Therapy

Jean-Michel Sallenave frequently collaborates with a consistent group of coauthors, including Bérengère Villeret, Ignacio García-Verdugo, Lydie Martín-Faivre, Saadé Kheir, and Maëlys Born-Bony. These collaborations indicate established research partnerships within related scientific areas.

Best Publications

  • Systemic Human ILC Precursors Provide a Substrate for Tissue ILC Differentiation.

    Ai Ing Lim;Ai Ing Lim;Ai Ing Lim;Yan Li;Yan Li;Silvia Lopez-Lastra;Silvia Lopez-Lastra;Silvia Lopez-Lastra;Ralph Stadhouders

  • Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes.

    Jean-Michel Sallenave;Jerry Shulmann;John Crossley;Manel Jordana

  • SLPI and elafin: one glove, many fingers.

    Steven E. Williams;Thomas I. Brown;Ali Roghanian;Jean-Michel Sallenave

  • Expression of natural antimicrobials by human placenta and fetal membranes.

    A.E. King;A. Paltoo;R.W. Kelly;J.-M. Sallenave

  • Food-Grade Bacteria Expressing Elafin Protect Against Inflammation and Restore Colon Homeostasis

    Jean-Paul Motta;Luis G. Bermúdez-Humarán;Céline Deraison;Céline Deraison;Céline Deraison;Laurence Martin;Laurence Martin;Laurence Martin

  • Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positive and gram-negative respiratory pathogens.

    A.J. Simpson;A.I. Maxwell;J.R.W. Govan;C. Haslett

  • Overexpressing mouse model demonstrates the protective role of Muc5ac in the lungs

    Camille Ehre;Erin N. Worthington;Rachael M. Liesman;Barbara R. Grubb

  • The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease

    Jean-Michel Sallenave

  • Adenoviral Gene Delivery of Elafin and Secretory Leukocyte Protease Inhibitor Attenuates NF-κB-Dependent Inflammatory Responses of Human Endothelial Cells and Macrophages to Atherogenic Stimuli

    Peter A. Henriksen;Peter A. Henriksen;Mary Hitt;Zhou Xing;Jun Wang

  • Secretory leukocyte proteinase inhibitor is a major leukocyte elastase inhibitor in human neutrophils.

    Jean-Michel Sallenave;Mustapha Si-Ta har;Gerard Cox;Michel Chignard

  • IL-33 Enhances Lipopolysaccharide-Induced Inflammatory Cytokine Production from Mouse Macrophages by Regulating Lipopolysaccharide Receptor Complex

    Quentin Espinassous;Elvira Garcia-de-Paco;Ignacio Garcia-Verdugo;Monique Synguelakis

  • Antimicrobial activity of antiproteinases.

    J.-M. Sallenave

  • Secretory leukocyte protease inhibitor and elafin/trappin-2: versatile mucosal antimicrobials and regulators of immunity.

    Jean-Michel Sallenave

  • Diagnostic importance of pulmonary interleukin-1β and interleukin-8 in ventilator-associated pneumonia

    Andrew Conway Morris;Kallirroi Kefala;Thomas S Wilkinson;Olga Lucia Moncayo-Nieto

  • Acute exposure to silica nanoparticles enhances mortality and increases lung permeability in a mouse model of Pseudomonas aeruginosa pneumonia.

    Mathilde Delaval;Sonja Boland;Brigitte Solhonne;Brigitte Solhonne;Marie-Anne Nicola

  • Modifying the protease, antiprotease pattern by elafin overexpression protects mice from colitis.

    Jean–Paul Motta;Jean–Paul Motta;Jean–Paul Motta;Laurent Magne;Laurent Magne;Delphyne Descamps;Delphyne Descamps;Corinne Rolland;Corinne Rolland;Corinne Rolland

  • Innate Immune Defences in the Human Uterus during Pregnancy

    A.E. King;R.W. Kelly;J.-M. Sallenave;A.D. Bocking

  • Intranasal Mucosal Boosting with an Adenovirus-Vectored Vaccine Markedly Enhances the Protection of BCG-Primed Guinea Pigs against Pulmonary Tuberculosis

    Zhou Xing;Christine T. McFarland;Jean-Michel Sallenave;Angelo Izzo

  • C5a mediates peripheral blood neutrophil dysfunction in critically ill patients

    Andrew Conway Morris;Kallirroi Kefala;Thomas S. Wilkinson;Kevin Dhaliwal

  • Aspergillus fumigatus-induced interleukin-8 synthesis by respiratory epithelial cells is controlled by the phosphatidylinositol 3-kinase, p38 MAPK, and ERK1/2 pathways and not by the toll-like receptor-MyD88 pathway.

    Viviane Balloy;Viviane Balloy;Jean-Michel Sallenave;Jean-Michel Sallenave;Yongzheng Wu;Yongzheng Wu;Lhousseine Touqui;Lhousseine Touqui

Frequent Co-Authors

Michel Chignard
Michel Chignard Institut Pasteur
Viviane Balloy
Viviane Balloy Sorbonne University
Christopher Haslett
Christopher Haslett University of Edinburgh
Jack Gauldie
Jack Gauldie McMaster University
Zhou Xing
Zhou Xing McMaster University
Mustapha Si-Tahar
Mustapha Si-Tahar François Rabelais University
Aleksander Edelman
Aleksander Edelman Université Paris Cité
Philippe Langella
Philippe Langella University of Paris-Saclay
Luis G. Bermúdez-Humarán
Luis G. Bermúdez-Humarán University of Paris-Saclay

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Jean-Michel Sallenave

Trending Scientists

Recently Published Articles